Section one: Contracting authority
one.1) Name and addresses
NHS England
Premier House, 60 Caversham Road,
Reading
RG1 7EB
Country
United Kingdom
NUTS code
UKK11 - Bristol, City of
Justification for not providing organisation identifier
Not on any register
Internet address(es)
Main address
Buyer's address
https://health-family.force.com/s/Welcome
one.2) Information about joint procurement
The contract is awarded by a central purchasing body
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://health-family.force.com/s/Welcome
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted to the above-mentioned address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
NHS England South East - Diabetic Eye Screening Programmes (DESP)
Reference number
C253273
two.1.2) Main CPV code
- 85100000 - Health services
two.1.3) Type of contract
Services
two.1.4) Short description
NHS England South East (NHSE) is seeking to commission a Provider(s) who have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements.
The procurement is divided into 5 lots within the South East as follows:
Lot 1: Kent and Medway (ICB Footprint)
Lot 2: Surrey Heartlands (ICB Footprint)
Lot 3: Hampshire and IOW (ICB Footprint)
Lot 4: Berkshire (Local Authority) and Frimley (ICB Footprint)
Lot 5: Oxfordshire and Buckinghamshire (Local Authority Footprint)
Providers may bid for one or all Lots. The Contracts will be for a term of 5 years, with the option to extend by 3 years, and services are planned to commence from 1st April 2025.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
• focus on improving uptake, reducing inequalities and improving outcomes
• is accessible across all service elements
• Is engaged, engaging and integrated, working effectively with service users and stakeholders to ensure seamless and high quality care
• safe, effective, high quality, wiht robust processes along the pathway
•
• embeds a culture of quality, improvement and learning
• is well-led, managed and staffed
There are three key elements of service delivery, namely:
• routine digital screening - from 2025 and 2026 all eligible patients should be managed on 12 or 24 month intervals .
• Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
Further information on the Diabetic Eye Screening Programme is available at;
https://www.gov.uk/topic/population-screening-programmes/diabetic-eye
The projected total contract values are as follows:
Lot 1: Kent and Medway - £17,755,303
Lot 2: Surrey Heartlands - £8,084,825
Lot 3: Hampshire and IOW - £16,695,800
Lot 4: Berkshire and Frimley - £11,311,121
Lot 5: Oxfordshire and Buckinghamshire - £9,927,015
TUPE is likely to apply to this procurement.
This exercise is being managed by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioner(s).
Interested providers will be able to view the opportunity and access the tender documentation via the 'Live Opportunities' list on the e-procurement system, Atamis, available on the following link: https://health-family.force.com/s/Welcome
two.1.5) Estimated total value
Value excluding VAT: £63,774,064
two.1.6) Information about lots
This contract is divided into lots: Yes
Tenders may be submitted for all lots
two.2) Description
two.2.1) Title
Kent and Medway
Lot No
1
two.2.2) Additional CPV code(s)
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKJ4 - Kent
two.2.4) Description of the procurement
NHS England South East (NHSE) is seeking to commission a Provider(s) who have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements.
Providers may bid for one or all Lots. The Contracts will be for a term of 5 years, with the option to extend by 3 years, and services are planned to commence from 1st April 2025.
The procurement is divided into 5 lots. Lot 1 covers Kent and Medway and has an eligible population of around 124,000 people. Please refer to the lot data sheet included within the tender documents for more information.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
• Identifies the eligible population and ensures effective delivery with maximum coverage
• Is safe, effective, high quality, externally and independently monitored, and quality assured
• Leads to earlier detection, appropriate referral, effective treatment and improved outcomes
• Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous professional development (CPD) and quality assurance (QA) schemes
• Has audit embedded in the service
• Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.
There are three key elements of service delivery, namely:
• Routine digital screening - from 2025 and 2026 all eligible patients should be managed on 12 or 24 month intervals for routine diabetic eye screening.
• Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £17,755,303
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
96
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2) Description
two.2.1) Title
Surrey Heartlands
Lot No
2
two.2.2) Additional CPV code(s)
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKJ2 - Surrey, East and West Sussex
two.2.4) Description of the procurement
NHS England South East (NHSE) is seeking to commission a Provider(s) who have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements., in line with the specified requirements.
The procurement is divided into 5 lots. Lot 2 covers Surrey Heartlands and has an eligible population of around 56,000 people. Please refer to the lot data sheet included within the tender documents for more information.
Providers may bid for one or all Lots. The Contracts will be for a term of 5 years, with the option to extend by 3 years, and services are planned to commence from 1st April 2025.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
• Identifies the eligible population and ensures effective delivery with maximum coverage
• Is safe, effective, high quality, externally and independently monitored, and quality assured
• Leads to earlier detection, appropriate referral, effective treatment and improved outcomes
• Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous professional development (CPD) and quality assurance (QA) schemes
• Has audit embedded in the service
• Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.
There are three key elements of service delivery, namely:
• Routine digital screening - from 2025 and 2026 all eligible patients should be managed on 12 or 24 month intervals for routine diabetic eye screening.
• Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £8,084,825
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
96
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2) Description
two.2.1) Title
Hampshire and Isle of Wight
Lot No
3
two.2.2) Additional CPV code(s)
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKJ3 - Hampshire and Isle of Wight
two.2.4) Description of the procurement
NHS England South East (NHSE) is seeking to commission a Provider(s) who have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements., in line with the specified requirements.
The procurement is divided into 5 lots. Lot 3 covers the Hampshire and Isle of Wight ICB area and has an eligible population of around 117,000 people Please refer to the lot data sheet included within the tender documents for more information.
Providers may bid for one or all Lots. The Contracts will be for a term of 5 years, with the option to extend by 3 years, and services are planned to commence from 1st April 2025.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
• Identifies the eligible population and ensures effective delivery with maximum coverage
• Is safe, effective, high quality, externally and independently monitored, and quality assured
• Leads to earlier detection, appropriate referral, effective treatment and improved outcomes
• Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous professional development (CPD) and quality assurance (QA) schemes
• Has audit embedded in the service
• Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.
There are three key elements of service delivery, namely:
• Routine digital screening - from 2025 and 2026 all eligible patients should be managed on 12 or 24 month intervals for routine diabetic eye screening.
• Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £16,695,800
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
96
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2) Description
two.2.1) Title
Berkshire & Frimley
Lot No
4
two.2.2) Additional CPV code(s)
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKJ - South East (England)
two.2.4) Description of the procurement
NHS England South East (NHSE) is seeking to commission a Provider(s) who have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements., in line with the specified requirements.
The procurement is divided into 5 lots. Lot 4 covers all of Berkshire and thethe Frimley ICB area and has an eligible population of around 79,000. Please refer to the lot data sheet included within the tender documents for more information.
Providers may bid for one or all Lots. The Contracts will be for a term of 5 years, with the option to extend by 3 years, and services are planned to commence from 1st April 2025.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
• Identifies the eligible population and ensures effective delivery with maximum coverage
• Is safe, effective, high quality, externally and independently monitored, and quality assured
• Leads to earlier detection, appropriate referral, effective treatment and improved outcomes
• Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous professional development (CPD) and quality assurance (QA) schemes
• Has audit embedded in the service
• Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.
There are three key elements of service delivery, namely:
• Routine digital screening - from 2025 and 2026 all eligible patients should be managed on 12 or 24 month intervals for routine diabetic eye screening.
• Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £11,311,121
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
96
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2) Description
two.2.1) Title
Oxfordshire and Buckinghamshire
Lot No
5
two.2.2) Additional CPV code(s)
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKJ1 - Berkshire, Buckinghamshire and Oxfordshire
two.2.4) Description of the procurement
NHS England South East (NHSE) is seeking to commission a Provider(s) who have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements., in line with the specified requirements.
The procurement is divided into 5 lots. Lot 5 covers the whole of Buckinghamshire and Oxfordshire and has an eligible population of around 69,000 people. Please refer to the lot data sheet included within the tender documents for more information.
Providers may bid for one or all Lots. The Contracts will be for a term of 5 years, with the option to extend by 3 years, and services are planned to commence from 1st April 2025.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
• ##########
There are three key elements of service delivery, namely:
• Routine digital screening - from 2025 and 2026 all eligible patients should be managed on 12 or 24 month intervals for routine diabetic eye screening.
• Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £9,927,015
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
96
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
three.1.3) Technical and professional ability
List and brief description of selection criteria
Details regarding the selection criteria are described within the ITT Bidder Instructions document. This includes details on the economic and financial standing tests that will be managed including the 'pass' score.
Minimum level(s) of standards possibly required
Minimum level(s) of standards possibly required: (no more than 10,000 characters)
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2024/S 000-001342
four.2.2) Time limit for receipt of tenders or requests to participate
Date
5 June 2024
Local time
12:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 6 (from the date stated for receipt of tender)
four.2.7) Conditions for opening of tenders
Date
5 June 2024
Local time
12:15pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.3) Additional information
Interested providers will be able to view this opportunity via the live opportunities list on the 'Health Family' e-procurement system, Atamis. Click on 'View our Live Opportunities' from the home page, available on the following link: https://health-family.force.com/s/Welcome.
Once you have found the opportunity (via the search function, using the title or reference number), to gain full access to the bid documentation (including questionnaires), you will need to click on 'Register interest' - this will take you to the log-in page.
If you are not already registered on the system, you will need to do so before gaining full access to the documentation and be able to submit a bid.
This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
six.4) Procedures for review
six.4.1) Review body
NHS England
Reading
Country
United Kingdom